Tag: antimalarial

Resistance to antimalarial drugs measured, mapped across Africa

Despite major progress in the global fight to end malaria, the parasite responsible for the disease has evolved resistance to every antimalarial drug deployed to date. Experts have long worried about the emergence of drug resistance to the current frontline treatment in Africa, a region that accounts for the overwhelming majority of malaria cases and

Early-stage clinical trial of antimalarial drug begins

Enrollment has begun in a Phase 1 clinical trial to test the safety of a new investigational drug designed to treat malaria, as well as its effect on the human body. The first-in-human study is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and